文献速递关节外科创伤骨科

膝关节大段骨缺损采用髓内钉稳定抗生素间隔物在两阶段假体周围感染治疗中的管理

Management of Large Segmental Bone Defects at the Knee With Intramedullary Stabilized Antibiotic Spacers During Two-Stage Treatment of Endoprosthetic Joint Infection.
PubMed 文献 · J Arthroplasty · 2021-01-18

回顾1998至2018年因膝关节感染行翻修或假体置换术、清创后骨缺损>6 cm的21例患者,第一阶段使用髓内钉稳定抗生素间隔物,静脉抗生素6周并口服至少6周,感染控制后二期植入假体。感染根除率86%,平均MSTS评分77%,平均膝关节活动度100°。多微生物感染患者既往手术次数更多,二期假体植入前需额外清创的比值比为12.0。

要点

  • 膝关节大段骨缺损(>6 cm)可先用髓内钉稳定抗生素间隔物维持稳定。
  • 两阶段间静脉抗生素6周、口服抗生素至少6周,感染控制后二期植入假体。

核心结论

  • 膝关节置换或假体取出后大段骨缺损使用髓内钉稳定抗生素间隔物可维持稳定,并获得高保肢率和假体转换率。

研究设计与样本

  • 回顾性研究,纳入1998至2018年因膝关节翻修全关节或假体感染治疗的患者。
  • 骨缺损>6 cm者在第一阶段清创后使用髓内钉稳定抗生素间隔物。
  • 共21例患者,平均年龄54±21岁。

主要发现

  • 多微生物生长占38%,凝固酶阴性葡萄球菌占24%,金黄色葡萄球菌占19%。
  • 第一阶段治疗后平均残余骨缺损为20 cm。
  • 感染根除18例(86%),平均MSTS评分77%,平均膝关节活动度100°。

关键数值与推荐

  • 骨缺损>6 cm者第一阶段使用髓内钉稳定抗生素间隔物。
  • 第一阶段后静脉抗生素6周,口服抗生素至少6周。
  • 炎症标志物消退且组织培养阴性后行二期假体植入。

临床怎么用

  • 对膝关节感染清创后大段骨缺损(>6 cm)可用髓内钉稳定抗生素间隔物作为两阶段治疗的第一阶段。
  • 需按方案完成静脉6周及口服至少6周抗生素,并在炎症标志物消退、培养阴性后行二期假体植入。
  • 多微生物感染患者应预期可能需要额外清创。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Following debridement of infected prostheses that require reconstruction with an endoprosthetic replacement (EPR), instability related to segmental residual bone defects present a challenge in management with 2-stage reimplantation. METHODS: We retrospectively reviewed all patients treated for revision total joint or endoprosthetic infection at the knee from 1998 to 2018. At our institution, patients with skeletal defects >6 cm following explant of prosthesis and debridement (stage 1) were managed with intramedullary nail-stabilized antibiotic spacers. Following stage 1, antimicrobial therapy included 6 weeks of intravenous antibiotics and a minimum of 6 weeks of oral antibiotics. Following resolution of inflammatory markers and negative tissue cultures, reimplantation (stage 2) of an EPR was performed. RESULTS: Twenty-one patients at a mean age of 54 ± 21 years were treated for prosthetic joint infection at the knee. Polymicrobial growth was detected in 38% of cases, followed by coagulase-negative staphylococci (24%) and Staphylococcus aureus (19%). Mean residual skeletal defect after stage 1 treatment was 20 cm. Prosthetic joint infection eradication was achieved in 18 (86%) patients, with a mean Musculoskeletal Tumor Society score of 77% and mean knee range of motion of 100°. Patients with polymicrobial infections had a greater number of surgeries prior to infection (P = .024), and were more likely to require additional debridement prior to EPR (odds ratio 12.0, P = .048). CONCLUSION: Management of large segmental skeletal defects at the knee following explant using intramedullary stabilized antibiotic spacers maintain stability and result in high rates of limb salvage with conversion to an endoprosthesis.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Ippolito JA, Thomson JE, Rivero SM, et al. Management of Large Segmental Bone Defects at the Knee With Intramedullary Stabilized Antibiotic Spacers During Two-Stage Treatment of Endoprosthetic Joint Infection. J Arthroplasty. 2021. PMID: 33546952. doi:10.1016/j.arth.2021.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。